Sabra Health Care [SBRA] vs Welltower [WELL] Detailed Stock Comparison
Sabra Health Care
NASDAQ
Loading...
Welltower
NYSE
Loading...
TLDR: Quick Comparison Summary
Based on 20 vital metrics comparison: Sabra Health Care wins in 14 metrics, Welltower wins in 6 metrics, with 0 ties. Sabra Health Care appears stronger overall.
View Metrics Details
Vital Metrics Comparison
| Metric | Sabra Health Care | Welltower | Better |
|---|---|---|---|
| P/E Ratio (TTM) | 24.29 | 91.01 | Sabra Health Care |
| Price-to-Book Ratio | 1.63 | 3.02 | Sabra Health Care |
| Debt-to-Equity Ratio | 91.74 | 47.36 | Welltower |
| PEG Ratio | 0.13 | 9.56 | Sabra Health Care |
| EV/EBITDA | 15.48 | 35.30 | Sabra Health Care |
| Profit Margin (TTM) | 24.84% | 12.18% | Sabra Health Care |
| Operating Margin (TTM) | 38.43% | 18.66% | Sabra Health Care |
| EBITDA Margin (TTM) | 38.43% | 18.66% | Sabra Health Care |
| Return on Equity | 6.66% | 3.45% | Sabra Health Care |
| Return on Assets (TTM) | 3.20% | 1.92% | Sabra Health Care |
| Free Cash Flow (TTM) | $310.54M | $2.20B | Welltower |
| Dividend Yield | 6.57% | 1.31% | Sabra Health Care |
| 1-Year Return | 17.98% | 39.85% | Welltower |
| Price-to-Sales Ratio (TTM) | 6.03 | 11.74 | Sabra Health Care |
| Enterprise Value | $6.81B | $122.49B | Welltower |
| EV/Revenue Ratio | 9.28 | 13.20 | Sabra Health Care |
| Gross Profit Margin (TTM) | 67.70% | 39.80% | Sabra Health Care |
| Revenue per Share (TTM) | $3 | $15 | Welltower |
| Earnings per Share (Diluted) | $0.76 | $1.79 | Welltower |
| Beta (Stock Volatility) | 0.82 | 0.92 | Sabra Health Care |
Performance
Key Stats
Valuation
Financials
Short Interest
Dividends
Sabra Health Care vs Welltower Stock Performance Analysis
Loading Price Chart...
Performance Comparison
Short-term Returns
| Stock | 1D | 1W | 1M | 3M | 6M | YTD |
|---|---|---|---|---|---|---|
| Sabra Health Care | 0.82% | 6.34% | 8.28% | 13.54% | 23.47% | 15.07% |
| Welltower | 0.57% | 3.13% | 4.13% | 12.57% | 12.36% | 33.85% |
Long-term Returns
| Stock | 1Y | 3Y | 5Y | 10Y | 15Y | 20Y |
|---|---|---|---|---|---|---|
| Sabra Health Care | 17.98% | 27.24% | 30.37% | -20.76% | -23.69% | 0.62% |
| Welltower | 39.85% | 115.88% | 180.81% | 156.52% | 265.38% | 361.42% |
Performance & Financial Health Analysis: Sabra Health Care vs Welltower
| Metric | SBRA | WELL |
|---|---|---|
| Market Information | ||
| Market Cap | $4.43B | $108.95B |
| Market Cap Category | Mid cap | Large cap |
| 10 Day Avg. Volume | 3,029,470 | 2,595,090 |
| 90 Day Avg. Volume | 2,589,517 | 2,434,917 |
| Last Close | $19.62 | $166.94 |
| 52 Week Range | $15.60 - $20.03 | $116.29 - $171.09 |
| % from 52W High | -2.05% | -2.43% |
| All-Time High | $72.39 (Apr 22, 2002) | $171.09 (Aug 06, 2025) |
| % from All-Time High | -72.90% | -2.43% |
| Growth Metrics | ||
| Quarterly Revenue Growth | 0.08% | 0.40% |
| Quarterly Earnings Growth | 1.73% | 0.19% |
| Financial Health | ||
| Profit Margin (TTM) | 0.25% | 0.12% |
| Operating Margin (TTM) | 0.38% | 0.19% |
| Return on Equity (TTM) | 0.07% | 0.03% |
| Debt to Equity (MRQ) | 91.74 | 47.36 |
| Cash & Liquidity | ||
| Book Value per Share (MRQ) | $11.31 | $53.98 |
| Cash per Share (MRQ) | $0.42 | $6.59 |
| Operating Cash Flow (TTM) | $338.84M | $2.61B |
| Levered Free Cash Flow (TTM) | $286.91M | $2.07B |
| Dividends | ||
| Last 12-Month Dividend Yield | 6.57% | 1.31% |
| Last 12-Month Dividend | $1.20 | $2.01 |
Valuation & Enterprise Metrics Analysis: Sabra Health Care vs Welltower
| Metric | SBRA | WELL |
|---|---|---|
| Price Ratios | ||
| P/E Ratio (TTM) | 24.29 | 91.01 |
| Forward P/E | 27.15 | 89.51 |
| PEG Ratio | 0.13 | 9.56 |
| Price to Sales (TTM) | 6.03 | 11.74 |
| Price to Book (MRQ) | 1.63 | 3.02 |
| Market Capitalization | ||
| Market Capitalization | $4.43B | $108.95B |
| Enterprise Value | $6.81B | $122.49B |
| Enterprise Value Metrics | ||
| Enterprise to Revenue | 9.28 | 13.20 |
| Enterprise to EBITDA | 15.48 | 35.30 |
| Risk & Other Metrics | ||
| Beta | 0.82 | 0.92 |
| Book Value per Share (MRQ) | $11.31 | $53.98 |
Financial Statements Comparison: Sabra Health Care vs Welltower
Financial Metrics
Loading Financial Charts...
Revenue
EBITDA
Operating Margin
Free Cash Flow
Long Term Debt
Profit Margin
Current Ratio
Operating Cash Flow
Income Statement (MRQ)
| Metric (MRQ) | SBRA | WELL |
|---|---|---|
| Revenue/Sales | $183.54M | $2.39B |
| Cost of Goods Sold | $59.93M | $1.46B |
| Gross Profit | $123.61M | $926.20M |
| Research & Development | N/A | N/A |
| Operating Income (EBIT) | $67.39M | $378.58M |
| EBITDA | $111.31M | $898.66M |
| Pre-Tax Income | $40.72M | $198.71M |
| Income Tax | $413,000 | $-5.52M |
| Net Income (Profit) | $40.30M | $257.27M |
Balance Sheet & Liquidity Metrics (MRQ)
| Metric (MRQ) | SBRA | WELL |
|---|---|---|
| Cash & Equivalents | $22.65M | $3.50B |
| Total Current Assets | $155.28M | $7.19B |
| Total Current Liabilities | $112.07M | $1.70B |
| Long-Term Debt | $2.42B | $17.01B |
| Total Shareholders Equity | $2.70B | $34.58B |
| Retained Earnings | $-1.91B | $-8.40B |
| Property, Plant & Equipment | N/A | $0 |
Cash Flow Statement Comparison (MRQ)
| Metric (MRQ) | SBRA | WELL |
|---|---|---|
| Operating Cash Flow | $82.99M | $699.61M |
| Capital Expenditures | N/A | N/A |
| Free Cash Flow | $80.26M | $587.44M |
| Debt Repayment | $-24.40M | $-134.28M |
| Common Stock Repurchase | $-5.39M | N/A |
Short Interest & Institutional Ownership Analysis
| Metric | SBRA | WELL |
|---|---|---|
| Shares Short | 19.22M | 10.24M |
| Short Ratio | 8.24 | 4.14 |
| Short % of Float | 0.11% | 0.02% |
| Average Daily Volume (10 Day) | 3,029,470 | 2,595,090 |
| Average Daily Volume (90 Day) | 2,589,517 | 2,434,917 |
| Shares Outstanding | 237.59M | 635.29M |
| Float Shares | 235.92M | 667.92M |
| % Held by Insiders | 0.01% | 0.00% |
| % Held by Institutions | 1.01% | 0.99% |
Dividend Analysis & Yield Comparison: Sabra Health Care vs Welltower
| Metric | SBRA | WELL |
|---|---|---|
| Last 12-Month Dividend | $1.20 | $2.01 |
| Last 12-Month Dividend Yield | 6.57% | 1.31% |
| 3-Year Avg Annual Dividend | $1.20 | $2.09 |
| 3-Year Avg Dividend Yield | 2.11% | 0.68% |
| 3-Year Total Dividends | $3.60 | $6.28 |
| Ex-Dividend Date | May 16, 2025 | Feb 25, 2025 |